Pronk, Nicolaas P. PhD; Baase, Catherine MD; May, Jeanette PhD; Terry, Paul PhD; Moseley, Karen BS
HealthPartners Institute, Bloomington, Minnesota (Dr Pronk), Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Dr Pronk); The Dow Chemical Company, Midland, Michigan (Dr Baase); Benedictine University, Lisle, Illinois (Dr May); Health Enhancement Research Organization (HERO), Edina, Minnesota (Dr Terry, Ms Moseley).
Address correspondence to: Nicolaas P. Pronk, PhD, President and Chief Science Officer, HealthPartners Institute, HealthPartners, 3311 E. Old Shakopee Road Bloomington, MN 55425 ([email protected]).
Funding: Information presented in this article was funded, in part, by the Robert Wood Johnson Foundation grant nos. 71440 and 71956 to the Health Enhancement Research Organization and from the National Academy of Medicine grant no. IOM-2000003570 to the HealthPartners Institute.
Conflicts of Interest: The authors indicate no conflicts of interest.